Pure Global

Effect of Omega 3 Fatty Acid supplementation on hepatic steatosis and liver stiffness in patients with nonalcoholic fatty liver disease: a Randomized Controlled Trial - Trial SLCTR_2017_033

Access comprehensive clinical trial information for SLCTR_2017_033 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2017_033
Not Applicable
Completed
Trial Details
Sri Lanka Clinical Trials Registry โ€ข SLCTR_2017_033
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Omega 3 Fatty Acid supplementation on hepatic steatosis and liver stiffness in patients with nonalcoholic fatty liver disease: a Randomized Controlled Trial

Study Focus

Interventional

Sponsor & Location

Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Bangladesh

Timeline & Enrollment

Not Applicable

Jan 01, 2018

N/A

ICD-10 Classifications

Liver disease, unspecified
Inflammatory liver disease, unspecified
Alcoholic liver disease, unspecified
Alcoholic fatty liver
Toxic liver disease, unspecified

Data Source

Sri Lanka Clinical Trials Registry

SLCTR_2017_033

Non-Device Trial